related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study Circulation 2007;116(12):1349–1355 236 Herce B, Nazeyrollas P, Lesaffre F, et al Risk factors for infection of implantable cardiac devices: data from a registry of 2496 patients Europace 2013;15(1):66–70 237 Ann HW, Ahn JY, Jeon YD, et al Incidence of and risk factors for infectious complications in patients with cardiac device implantation Int J Infect Dis 2015;36:9–14 238 Athan E, Chu VH, Tattevin P, et al Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices JAMA 2012;307(16):1727–1735 239 Greenspon AJ, Prutkin JM, Sohail MR, et al Timing of the most recent device procedure influences the clinical outcome of leadassociated endocarditis results of the MEDIC (multicenter electrophysiologic device infection cohort) J Am Coll Cardiol 2012;59(7):681– 687 240 Deharo JC, Quatre A, Mancini J, et al Longterm outcomes following infection of cardiac implantable electronic devices: a prospective matched cohort study Heart 2012;98(9):724– 731 241 Meier-Ewert HK, Gray ME, John RM Endocardial pacemaker or defibrillator leads with infected vegetations: a single-center experience and consequences of transvenous extraction Am Heart J 2003;146:339–344 242 Ruttmann E, Hangler HB, Kilo J, et al Transvenous pacemaker lead removal is safe and effective even in large vegetations: an analysis of 53 cases of pacemaker lead endocarditis Pacing Clin Electrophysiol 2006;29:231–236 243 Gaynor SL, Zierer A, Lawton JS, et al Laser assistance for extraction of chronically implanted endocardial leads: infectious versus noninfectious indications Pacing Clin Electrophysiol 2006;29:1352–1358 244 NICE Short Clinical Guidelines Technical Team Prophylaxis Against Infective Endocarditis: Antimicrobial Prophylaxis Against Infective Endocarditis in Adults and Children Undergoing Interventional Procedures NICE Clinical Guideline 64 National Institute for Health and Clinical Excellence: London; 2008 http://www.nice.org.uk/nicemedia/pdf/CG64NICEgu 245 Glenny AM, Oliver R, Roberts GJ, Hooper L, Worthington HV Antibiotics for the prophylaxis of bacterial endocarditis in dentistry Cochrane Database Syst Rev 2013;(10) [CD003813] 246 Sun LC, Lai CC, Wang CY, et al Risk factors for infective endocarditis in children with congenital heart diseases - a nationwide population-based case control study Int J Cardiol 2017 247 van Rijen MM, Bode LG, Baak DA, Kluytmans JA, Vos MC Reduced costs for staphylococcus aureus carriers treated prophylactically with mupirocin and chlorhexidinein cardiothoracic and orthopaedic surgery PLoS ONE 2012;7:e43065 248 Bode LG, Kluytmans JA, Wertheim HF, et al Preventing surgical-site infections in nasal carriers of staphylococcus aureus N Engl J Med 2010;362:9–17 249 Naik RJ, Patel NR, Wang M, Shah NC Infective endocarditis prophylaxis: current practice trend among paediatric cardiologists: are we following the 2007 guidelines? Cardiol Young 2016;26(6):1176–1182 250 Pharis CS, Conway J, Warren AE, Bullock A, Mackie AS The impact of 2007 infective endocarditis prophylaxis guidelines on the practice of congenital heart disease specialists Am Heart J 2011;161(1):123–129 251 Grattan MJ, Power A, Fruitman DS, Islam S, Mackie AS The impact of infective endocarditis